Preclinical toxicology from a top pre-clinical Contract Research Organization in Eastern Europe.
We are an independent Contract Research Organization operating out of the United States that conducts pre-clinical medicine testing in top-notch, Good Laboratory Practices certified testing laboratories in Kiev, Ukraine. Our testing sites are sponsored by the Ukrainian National Academy of Medical Sciences and Health Department and provide support for commercial development of new medicine discoveries as part of their main purpose. The CRO was created to provide the top-notch, low-cost services of these facilities to start-up bio-technology companies in the USA and Europe, thereby providing them with an attractive option for advancing development programs rapidly and at much lower cost than other commercial Contract Research Organizations. We offer a wide range of pre-clinical services including medicine safety, chronic and acute toxicity, pharma screening, bioavailability, bio-equivalence , and extensive in vitro and in vivo screening for anticancer activity.
Our pre-clinical Contract Research Organization is able to price pre-clinical testing far below other Contract Research Organizations because we maintain a very low overhead in the U.S. and conduct all trials in Kiev, UA where personnel and laboratory costs are much lower. Our team in the United States is comprised of only of the organization principals who work directly with customers; we have no marketing expenses other than our site, and no head offices, administrative staff or other overhead to inflate costs. We have much lower trials conduct costs in Kiev, UA due to much lower workers rates and are able to provide our most attractive pricing for long-term and more intricate pre-clinical trials where labor is the greatest portion of the overall price. Since we utilize the same reliable international suppliers for animal models, reagents and lab materials as other Contract Research Organizations, we don’t have any cost savings on these items and so less overall cost advantage for very short-term preclinical studies. However, regardless of your trial protocol and length, our goal is to provide our customers the best possible value for their investment.